Amgen CFO talks Q2 earnings, obesity drug, and growth
Amgen (AMGN) posted second quarter revenue of $8.4 billion, topping expectations of $8.34 billion. Sales rose by 20% in the ...
Amgen (AMGN) posted second quarter revenue of $8.4 billion, topping expectations of $8.34 billion. Sales rose by 20% in the ...
President Biden and Sen. Bernie Sanders (D-Vt.) are calling for price cuts on popular GLP-1 weight-loss drugs. Pharmaceutical stocks Novo ...
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.
Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.